Summary
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. Its the latest example of limits imposed by insurance that disrupt treatments for patients.
Source: The New York Times
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
